Anti-Peripherin Antibody, clone 1D4, ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 1D4 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Peripherin. It targets an epitope within 17 amino acids from the C-terminal region.
• Immunogen: KLH-conjugated linear peptide corresponding to 17 amino acids from the C-terminal region of human Peripherin.
• Application: Anti-Peripherin, clone 1D4 ZooMAb , Cat. No. ZRB1174, is a highly specific rabbit recombinant monoclonal antibody that targets Peripherin and has been tested for use in Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
• Target description: Peripherin (UniProt: P41219; also known as Neurofilament 4) is encoded by the PRPH (also known as NEF4, PRPH1) gene (Gene ID: 5630) in human. Peripherin is a member of the intermediate filament family. It is classified as a class-III neuronal intermediate filament protein that is expressed mainly in neurons of the peripheral nervous system. It is also found in neurons of the central nervous system that have projections toward peripheral structures, such as spinal motor neurons. Its expression is also reported in certain neuroendocrine tumors. Peripherin is shown to coexist with the neurofilament triplet proteins (neurofilament light, medium, and heavy chain). PRPH gene expression is reported to be the highest in late embryonic and early postnatal brain and declines somewhat before expression of triplet protein sharply rises. A possible peripherin involvement in amyotrophic lateral sclerosis (ALS) pathogenesis has been suggested based on studies with transgenic mice that display over-expression and with a toxic splicing variant of the gene. Two isoforms of peripherin have been described that are produced by alternative splicing. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Leung, CL., et al., (2004). Brain Pathol. 14(3); 290-296; Yuan, A., et al. (2012). J. Neurosci. 32(25); 8501-8508).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose. Normal appearance is a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 30 μg/mL after reconstitution at 25 μL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.